VRTX:Vertex Pharmaceuticals Inc Snapshot | Charting | News | Options
$483.05 NASDAQ 10:08p ET
February 2 '26 		WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on VRTX
    No News Available
    Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chr...
    10:17a ET January 26 '26 PR Newswire
    Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chr...
    12:56p ET January 23 '26 GlobeNewswire
    Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
    12:25p ET January 8 '26 PR Newswire
    From Insulin Injections to Functional Cures: Regenerative Medicine Re...
    11:59a ET December 16 '25 GlobeNewswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.